Atrás
Scinai Immunotherapeutics Ltd (SCNI) Ganando
Gráfico del Precio de Acciones SCNI
SCNI Ganando
Scinai Immunotherapeutics Ltd
$0.67
-0.95%
$0
Al cierre: Mar 24, 16:00:00 GMT-4
$0.67
0%
$0
Mercado Posterior: Mar 24, 18:44:12 GMT-4
Estadísticas clave
Cierre Anterior
$0.6801
Precio de apertura
$0.6716
Rango del día
$0.6716 - $0.6768
Rango de 52 semanas
$0.613 - $6.18
Volumen
4.2K
Volumen promedio
47.6K
Rendimiento de dividendos
--
EPS (TTM)
0.00
Cap. de mercado
$2.3M
¿Qué es SCNI?
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.